Title of article
Papillary Carcinoma of Thyroid Gland in a Patient Treated with Recombinant Growth Hormone
Author/Authors
Amirhakimi, G.H Department of Surgery, Shiraz University of Medical Sciences, Shiraz , Talei, A Department of Surgery, Shiraz University of Medical Sciences, Shiraz
Pages
2
From page
45
To page
46
Abstract
The first successful treatment of growth hormone (GH) deficient
children with GH extracted from human pituitary was introduced
during late 1950's. The subsequent availability and
use of recombinant GH (rhGH) for different clinical conditions
raised the question of whether this new therapeutic modality
increases the risk of certain conditions such as leukemia or malignancy.
Herein, we report on a 22-year-old man who was
diagnosed as a case of GH deficiency at the age of 11 years,
was treated with rhGH for 6 years and who developed papillary
carcinoma of the thyroid gland 6 years after cessation of the
treatment.
Keywords
Growth hormone , papillary carcinoma , thyroid gland , malignancy
Journal title
Astroparticle Physics
Serial Year
2004
Record number
2447251
Link To Document